Predicting Factors for Mortality in Congenital Heart Disease Patients After Shunt Procedure in Developing Country.

Predicting Factors for Mortality in Patients After the Modified Blalock-Taussig Shunt Procedure in Developing Country: a Retrospective Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05800691

Enrollment

197

Registered

2023-04-05

Start date

2020-11-01

Completion date

2021-01-31

Last updated

2023-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cyanotic Congenital Heart Disease

Brief summary

Blalock Taussig (BT) is a palliative procedure that preserves blood circulation to the lungs and alleviates cyanosis in patients with congenital heart diseases and reduced pulmonary blood flow. BT shunt remains a routinely performed procedure in developing countries before definitive surgery. However, evidence on predictors factors of mortality after this procedure is still scarce in Indonesia.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to 18 Years

Inclusion criteria

* All CHD pediatric patients with a previous history of BT shunt procedure.

Exclusion criteria

* Pediatric patients with incomplete medical records

Design outcomes

Primary

Measure	Time frame	Description
In-Hospital Mortality	November 2020 - January 2021	Death occured to patients during in hospital stay

Countries

Indonesia

Outcome results